Show simple item record

dc.contributor.authorSmith, Christopher
dc.contributor.authorPatterson-Cross, Ryan
dc.contributor.authorWoodward, Orla
dc.contributor.authorLewis, Jo
dc.contributor.authorChiarugi, Davide
dc.contributor.authorMerkle, Florian
dc.contributor.authorGribble, Fiona
dc.contributor.authorReimann, Frank
dc.contributor.authorAdriaenssens, Alice
dc.date.accessioned2022-04-22T23:30:24Z
dc.date.available2022-04-22T23:30:24Z
dc.date.issued2022-04-14
dc.identifier.issn0195-6663
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/336383
dc.description.abstractOBJECTIVE: The hypothalamus is a key region of the brain implicated in homeostatic regulation, and is an integral centre for the control of feeding behaviour. Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are incretin hormones with potent glucoregulatory function through engagement of their respective cognate receptors, GLP-1R and GIPR. Recent evidence indicates that there is a synergistic effect of combining GIP- and GLP-1-based pharmacology on appetite and body weight. The mechanisms underlying the enhanced weight loss exhibited by GIPR/GLP-1R co-agonism are unknown. Gipr and Glp1r are expressed in the hypothalamus in both rodents and human. To better understand incretin receptor-expressing cell populations, we compared the cell types and expression profiles of Gipr- and Glp1r-expressing hypothalamic cells using single-cell RNA sequencing. METHODS: Using Glp1r-Cre or Gipr-Cre transgenic mouse lines, fluorescent reporters were introduced into either Glp1r- or Gipr-expressing cells, respectively, upon crossing with a ROSA26-EYFP reporter strain. From the hypothalami of these mice, fluorescent Glp1rEYFP + or GiprEYFP + cells were FACS purified and sequenced using single-cell RNA sequencing. Transcriptomic analysis provided a survey of both non-neuronal and neuronal cells, and comparisons between Glp1rEYFP+ and GiprEYFP + populations were made. RESULTS: A total of 14,091 Glp1rEYFP+ and GiprEYFP + cells were isolated, sequenced and taken forward for bioinformatic analysis. Both Glp1rEYFP+ and GiprEYFP + hypothalamic populations were transcriptomically highly heterogeneous, representing vascular cell types, oligodendrocytes, astrocytes, microglia, and neurons. The majority of GiprEYFP + cells were non-neuronal, whereas the Glp1rEYFP + population was evenly split between neuronal and non-neuronal cell types. Both Glp1rEYFP+ and GiprEYFP + oligodendrocytes express markers for mature, myelin-forming oligodendrocytes. While mural cells are represented in both Glp1rEYFP+ and GiprEYFP + populations, Glp1rEYFP + mural cells are largely smooth muscle cells, while the majority of GiprEYFP + mural cells are pericytes. The co-expression of regional markers indicate that clusters of Glp1rEYFP+ and GiprEYFP + neurons have been isolated from the arcuate, ventromedial, lateral, tuberal, suprachiasmatic, and premammillary nuclei of the hypothalamus. CONCLUSIONS: We have provided a detailed comparison of Glp1r and Gipr cells of the hypothalamus with single-cell resolution. This resource will provide mechanistic insight into how engaging Gipr and Glp1r cells of the hypothalamus may result in changes in feeding behaviour and energy balance.
dc.publisherElsevier BV
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectAppetite
dc.subjectFeeding
dc.subjectGlucagon-like peptide-1
dc.subjectGlucose-dependent insulinotropic polypeptide
dc.subjectGut-brain axis
dc.subjectHypothalamus
dc.subjectTranscriptomics
dc.titleA comparative transcriptomic analysis of Glucagon-like peptide-1 receptor- and glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus
dc.typeArticle
dc.publisher.departmentDepartment of Clinical Biochemistry
dc.date.updated2022-04-22T10:08:37Z
prism.publicationDate2022
prism.publicationNameAppetite
prism.startingPage106022
dc.identifier.doi10.17863/CAM.83800
dcterms.dateAccepted2022-03-26
rioxxterms.versionofrecord10.1016/j.appet.2022.106022
rioxxterms.versionAM
dc.contributor.orcidGribble, Fiona [0000-0002-4232-2898]
dc.contributor.orcidReimann, Frank [0000-0001-9399-6377]
dc.identifier.eissn1095-8304
rioxxterms.typeJournal Article/Review
pubs.funder-project-idWellcome Trust (220271/Z/20/Z)
pubs.funder-project-idMedical Research Council (MC_UU_12012/3)
pubs.funder-project-idWellcome Trust (211221/Z/18/Z)
cam.orpheus.success2022-04-22 - Embargo set during processing via Fast-track
cam.depositDate2022-04-22
pubs.licence-identifierapollo-deposit-licence-2-1
pubs.licence-display-nameApollo Repository Deposit Licence Agreement
rioxxterms.freetoread.startdate2023-04-14


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's licence is described as Attribution-NonCommercial-NoDerivatives 4.0 International